通过通过TREM2-TLR4/NF-κB通路调节微质极化,FGF20可以缓解缺血性中风中的神经炎症
Liyun Zhu1, Shufei Guo2, Zhengyi Wang2
1Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China; The First People's Hospital of Yuhang District, Hangzhou 311100, China.
Cellular immunology
|March 12, 2026
概括
纤维细胞生长因子20 (FGF20) 通过重编程微质来减少缺血性中风后的大脑损伤. FGF20将微质从有害的M1转移到保护的M2状态,抑制神经炎症.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 微质表现出双极化 (M1/M2),影响神经炎症和中风的结果.
- 纤维细胞生长因子20 (FGF20) 是一种已知的神经变因子,但其在微质偏振中的作用尚未被探索.
研究的目的:
- 调查FGF20在调节微质偏振和减轻神经炎症后缺血性中风中的新功能.
- 阐明FGF20免疫调节效应的潜在分子机制.
主要方法:
- 采用了一种中脑动脉封闭 (MCAO) 的老鼠模型,并进行了脑内静脉FGF20的注射.
- 进行RT-PCR,免疫光染色和体外初级微质细胞检测.
- 研究了TLR4/NF-κB和TREM2信号通路以及FGFR1抑制的作用.
主要成果:
- 在MCAO大鼠中,FGF20显著降低了心脏病发作量,并改善了神经功能.
- 在微质中,FGF20抑制了M1标记物 (例如CD86,TNF-α) 和增强了M2标记物 (例如IL-10,Arg-1).
- 在体外,FGF20抑制了LPS诱导的M1极化,下调的TLR4/NF-κB和上调的TREM2,TREM2和TLR4/NF-κB调节的途径是不同的.
结论:
- FGF20充当微质偏振的双调节器,促进M2表型和抑制M1表型.
- FGF20集成了TREM2介导的信号与FGFR1依赖和独立抑制TLR4/NF-κB.
- 通过向微质免疫调节,FGF20显示出对缺血性中风的治疗潜力.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...